Published in Br J Cancer on July 01, 1981
A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49. Cancer Biol Ther (2010) 1.56
Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue. Clin Cancer Res (2006) 1.17
Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity. Proc Natl Acad Sci U S A (1989) 1.03
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size. Eur J Cancer (2009) 1.02
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy. Bioconjug Chem (2011) 0.96
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies. Br J Cancer (1982) 0.94
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling. J Nucl Med (2014) 0.91
Cellular distribution of monoclonal antibody in human tumours after i.v. administration. Br J Cancer (1981) 0.86
The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach. Br J Cancer (1982) 0.83
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method. EJNMMI Res (2012) 0.78
Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system. Proc Natl Acad Sci U S A (1984) 0.77
The production of a bispecific anti-CEA, anti-hapten (4-amino-phthalate) hybrid-hybridoma. J Natl Med Assoc (1991) 0.75
Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody. Br J Cancer (1991) 0.75
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature (1977) 16.54
Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell (1977) 8.46
Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer (1978) 4.28
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med (1980) 2.50
The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res (1957) 1.98
In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature (1974) 1.96
Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen. Br Med J (1980) 1.82
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer (1980) 1.34
Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Cancer Res (1973) 1.31
Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen. J Immunol (1980) 1.29
Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20
Monoclonal antibodies to detect human tumours: an experimental approach. J Clin Pathol (1981) 1.15
Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen. Br J Cancer (1981) 1.05
Preliminary therapeutic and localization studies with human chorionic gonadotrophin. Cancer Res (1980) 0.91
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol (2001) 11.35
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J (1972) 5.48
A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol (1977) 3.77
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. Br Med J (Clin Res Ed) (1986) 3.52
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1992) 2.90
The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron (1993) 2.75
Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer (1972) 2.53
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17
Clinical and economic benefits of ramipril: an Australian analysis of the HOPE study. Intern Med J (2003) 2.16
Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res (1982) 2.07
Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem (2001) 1.96
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet (1976) 1.92
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88
Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A (2001) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
Biochemical monitoring of cancer. A review. Ann Clin Biochem (1976) 1.83
The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer (1973) 1.81
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. J Clin Oncol (1993) 1.79
Audit of general practitioner referrals to a surgical assessment unit: new methods to improve the efficacy of the acute surgical service. Br J Surg (1996) 1.77
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Are breast cancer axillary node micrometastases worth detecting? J Pathol (1990) 1.57
Studies on the attachment of myristic and palmitic acid to cell proteins in human squamous carcinoma cell lines: evidence for two pathways. EMBO J (1985) 1.52
Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut (2000) 1.50
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Clin Oncol (1997) 1.49
StarClose vascular closure device: safety and efficacy of deployment and reaccess in a neurointerventional radiology service. AJNR Am J Neuroradiol (2010) 1.48
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Four-year evaluation of a direct-access fibreoptic sigmoidoscopy service. Ann R Coll Surg Engl (1996) 1.47
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol (1981) 1.46
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
Potential pathological application of immunocytochemical methods to the detection of micrometastases. Cancer Res (1980) 1.41
High-resolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and non-synaptic sites in rat hippocampus. Neuroscience (1995) 1.40
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
Intrathoracic phaeochromocytoma. Br J Surg (1970) 1.36
Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCEA-2. Preparation and chemical characterisation. Immunochemistry (1973) 1.34
Morphological responses to corticotrophin and cyclic AMP by adult rat adrenocortical cells in monolayer culture. J Endocrinol (1973) 1.31
Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
The pathology of the adrenal gland in Cushing's syndrome. J Pathol Bacteriol (1967) 1.23
CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study. Invest Cell Pathol (1981) 1.22
Studies on the binding of 125I-labelled corticotrophin to isolated rat adrenocortical cells. J Endocrinol (1975) 1.19
Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med (1983) 1.17
Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes. J Biol Chem (2001) 1.17
Immunoreactive calcitonin production by human lung carcinoma cells in culture. Br J Cancer (1975) 1.16
N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis. J Natl Cancer Inst (1981) 1.16
Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines. Br J Cancer (2012) 1.15
Monoclonal antibodies to detect human tumours: an experimental approach. J Clin Pathol (1981) 1.15
Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (1983) 1.12
Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin. Am Heart J (1971) 1.11
Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer. Clin Cancer Res (1997) 1.11
Synaptic and nonsynaptic localization of the GluR1 subunit of the AMPA-type excitatory amino acid receptor in the rat cerebellum. J Neurosci (1994) 1.11
Father-son testicular malignancy. Does genetic anticipation occur? Cancer (1980) 1.10
Identification of functional ionotropic glutamate receptor proteins in pancreatic beta-cells and in islets of Langerhans. FEBS Lett (1995) 1.09
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. J Clin Oncol (2000) 1.09
Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol (1991) 1.08
The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer (1974) 1.08
The accuracy of endoscopic diagnosis of gastric carcinoma and the conventional barium meal. Clin Oncol (1978) 1.08
Human breast tumour-induced osteolysis and prostaglandins. Prostaglandins (1976) 1.07
Monolayer culture of normal adult and neoplastic cells of the rat and human adrenal cortex. Proc R Soc Med (1974) 1.06
Pathology of primary aldosteronism. Cancer (1966) 1.06
Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen. Br J Cancer (1981) 1.05
Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: cellular and subcellular distribution in the rat forebrain. Neuroscience (1993) 1.04
Report of the workshop on the carcinoembryonic antigen (cea): the present position and proposals for future investigation. Int J Cancer (1974) 1.04
Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer (1984) 1.04
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer (1980) 1.03
A drip is unnecessary after cholecystectomy. J R Coll Surg Edinb (1992) 1.03
Carcinoembryonic antigen and urothelial carcinoma. Br J Urol (1973) 1.03
The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India. J Clin Pharm Ther (2010) 1.02
The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol (1988) 1.01
Alpha-globulins in the surveillance of colorectal cancer. Biomedicine (1976) 1.01
Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia. Biosci Rep (1981) 1.01
Isolation and characterization of a major glycoprotein from milk-fat-globule membrane of human breast milk. Biochem J (1981) 1.00
Preparation and identification of human breast epithelial cells in culture. Int J Cancer (1980) 1.00
Identification of lectin-purified neural glycoproteins, GPs 180, 116, and 110, with NMDA and AMPA receptor subunits: conservation of glycosylation at the synapse. J Neurochem (1998) 1.00
The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J Neurochem (2001) 0.99
Biochemical markers in bronchogenic carcinoma. Br J Dis Chest (1978) 0.99
Letter: Syncytiotrophoblasts in malignant testicular tumours. Lancet (1976) 0.99
Localization of the glutamate receptor subunit GluR1 on the surface of living and within cultured hippocampal neurons. Neuroscience (1996) 0.99
Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg (1994) 0.99
Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch A Pathol Anat Histol (1982) 0.99
A marker of human foetal endoderm defined by a monoclonal antibody involves Type 1 blood group chains. Mol Immunol (1983) 0.99
Homer-1c/Vesl-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1alpha: evidence for an anchoring function. Mol Cell Neurosci (2000) 0.98
A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98
Polycyclic hydrocarbon activation and metabolism in epithelial cell aggregates prepared from human mammary tissue. Int J Cancer (1980) 0.97
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. J Clin Oncol (1987) 0.97
Mouse brain and muscle tissues constitutively express high levels of Homer proteins. Eur J Biochem (2000) 0.97
Evidence for a C-terminal tyrosine residue in human and mouse B-lymphocyte membrane mu chains. Nature (1978) 0.96
CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. J Cancer Res Clin Oncol (1981) 0.96
Effects of endocrine therapy on steroid-receptor content of breast cancer. Br J Cancer (1982) 0.96